Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | PPM1B | O75688 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.31 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | PPP5C | P53041 | 1/20 | 0.31 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1014782 | 0.81 | KDM4E (0.31) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL375777 | 0.69 | — | — | |
| SCHEMBL2470524 | 0.69 | — | — | |
| SCHEMBL4165018 | 0.65 | LMNA (0.42) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL11752874 | 0.62 | — | — | |
| SCHEMBL19107418 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL910480 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL14187990 | 0.60 | KDM4E (0.38) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL21999910 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC | |
| SCHEMBL16923832 | 0.60 | KDM4E (0.53) | KDM4EGMNNPPM1BLMNAPPP1CC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113461754-B | Base-modified adriamycin prodrug and preparation method and application thereof | 沈阳药科大学 | 2022-08-23 | — | — | CN | claimed |
| CN-113461754-A | Base-modified adriamycin prodrug and preparation method and application thereof | 沈阳药科大学 | 2021-10-01 | — | — | CN | claimed |
| CN-109771661-B | Oxcetitinib brain-targeted drug delivery system and application thereof in resisting lung cancer brain metastasis tumor | 南京医科大学 | 2021-08-31 | — | — | CN | claimed |
| CN-113461754-B | Base-modified adriamycin prodrug and preparation method and application thereof | 沈阳药科大学 | 2022-08-23 | — | — | CN | disclosed |
| CN-114129735-A | Cabazitaxel-fatty acid conjugate and nano preparation thereof | 苏州裕泰医药科技有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-113461754-A | Base-modified adriamycin prodrug and preparation method and application thereof | 沈阳药科大学 | 2021-10-01 | — | — | CN | disclosed |
| CN-109771661-B | Oxcetitinib brain-targeted drug delivery system and application thereof in resisting lung cancer brain metastasis tumor | 南京医科大学 | 2021-08-31 | — | — | CN | disclosed |
| US-20060141632-A1 | New methods and kits for sequencing polypeptides | THE PROCTER & GAMBLE CO. | 2006-06-29 | — | — | US | disclosed |
| EP-1145012-B1 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | PROCTER & GAMBLE (US) | 2004-08-18 | — | — | EP | disclosed |
| EP-1356297-A2 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-29 | — | — | EP | disclosed |
| WO-2002008767-A2 | METHODS AND KITS FOR SEQUENCING POLYPEPTIDES | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-31 | — | — | WO | disclosed |